help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsui, H.
Right arrow Articles by Takahashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, H.
Right arrow Articles by Takahashi, T.
Endocrinology Vol. 142, No. 11 4918-4929
Copyright © 2001 by The Endocrine Society


ARTICLES

Mouse Testicular Leydig Cells Express Klk21, a Tissue Kallikrein That Cleaves Fibronectin and IGF-Binding Protein-3

Hitoshi Matsui and Takayuki Takahashi

Division of Biological Sciences, Hokkaido University Graduate School of Science, Sapporo 060-0810, Japan

Address all correspondence and requests for reprints to: Dr. Takayuki Takahashi, Division of Biological Sciences, Hokkaido University School of Science, Sapporo 060-0810, Japan. E-mail: ttakaha{at}sci.hokudai.ac.jp


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have cloned a type of cDNA for a functional glandular kallikrein, designated as mouse Klk21 (mKlk21), from the adult mouse testis cDNA library. mKlk21 was expressed in the kidney, submaxillary glands, and testis of the mouse. In the testis, mKlk21 mRNA was detectable at 4 wk of postnatal development and became more prominent thereafter. The mKlk21 gene was expressed exclusively in the Leydig cells of adult mice. When Leydig cells isolated from 2-wk-old mouse testis were cultured in the presence of T, mKlk21 expression was induced significantly. Active recombinant mKlk21 showed trypsin-like specificity, favorably cleaving Arg-X bonds of synthetic peptide substrates. The enzyme activity was strongly inhibited with typical serine protease inhibitors. mKlk21 hydrolyzed casein, gelatin, fibronectin, and IGF-binding protein-3 (IGFBP-3). As in mKlk21, IGF-I and IGFBP-3 were expressed in the Leydig cells of the adult mouse testis, although the transcript of IGFBP-3 was not detected in all of the observed cells. The culture medium of Leydig cells isolated from adult mouse testes contained an mKlk21-like enzyme activity capable of degrading IGFBP-3. These results suggest that mKlk21 plays a role in Leydig cell function in the adult mouse testis.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
MAMMALIAN SPERMATOGENESIS is classically divided into three major developmental phases: spermatogonial maturation and multiplication, meiosis, and spermiogenesis. In the newborn mouse testis, spermatogonia and Sertoli cells exist and undergo a series of mitotic divisions. Meiosis begins 9 d postnatally, and spermatocytes undergo two consecutive divisions to produce the haploid spermatids. The onset of spermiogenesis occurs by 20 d, and spermatids are differentiated to spermatozoa. This process is not only controlled by endocrine hormones, but also is locally regulated by various factors (1). Leydig cells and Sertoli cells play an important role in both types of regulation (2).

Tissue or glandular kallikreins (Klks) are a subfamily of many structurally related serine proteases (3, 4, 5). In humans, this gene subfamily comprises at least 15 genes (5, 6, 7, 8, 9, 10, 11), including three well known members, namely, tissue kallikrein, human glandular kallikrein, and prostate-specific antigen (PSA). On the other hand, in the mouse, this subfamily is reportedly comprised of at least 27 genes (3, 4, 12, 13). Existing evidence indicates that about half of the mouse genes are functional and expressed (4). Some functional Klks have been biochemically characterized, whereas other such proteins remain unidentified. Mouse Klk21 (mKlk21), which is among the unidentified Klks species, is of interest because expression of this gene in the mouse testis has already been demonstrated (14).

In our attempt to elucidate the functional roles of proteolytic enzymes in the mammalian reproductive organs, we isolated and identified cDNAs encoding a variety of proteases expressed in the adult mouse testis. These proteases included mKlk21, mKlk24, and mKlk27 (13); of these, mKlk21 was expressed most abundantly in this organ. In the present study we determined the complete nucleotide sequence of mKlk21 and examined its testicular expression as well as its enzymatic properties to establish a basis for future physiological studies. The present data show that mKlk21 is indeed a serine protease expressed specifically in the Leydig cells of the adult mouse testis. Furthermore, the enzyme is shown to be capable of hydrolyzing certain extracellular matrix proteins as well as IGF-binding protein-3 (IGFBP-3). The current study also demonstrates that IGFBP-3 mRNA is notably expressed in the Leydig cells expressing mKlk21. These results suggest the possible involvement of mKlk21 in the regulation of Leydig cell function in the mouse testis after sexual dimorphism of expression occurs.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Mice (strain C57BL/6NCrj) were obtained from Charles River Laboratories, Inc. (Yokohama, Japan). The animals were kept under controlled conditions (temperature, 25 C; 14 h of light, 10 h of darkness) and allowed free access to food and water. The animals were sacrificed by cervical dislocation, and the relevant tissues were rapidly removed, frozen in liquid N2, and stored at -80 C until use. Experimental procedures used in this study were approved by the committee of the Center for Experimental Plants and Animals, Hokkaido University.

Cell culture
Mouse B16 melanoma cells (RCB 0557) were obtained from the RIKEN Cell Bank (Tsukuba, Japan) and were cultured as described previously (13). The mouse testicular cell line TM3 (Leydig cells) was obtained from American Type Culture Collection (Manassas, VA). Cells were grown according to the manufacturer’s instructions.

RNA isolation
Total RNAs were prepared from frozen tissues or confluent monolayers of melanoma cells using the guanidine isothiocyanate-cesium chloride method (15). Polyadenylated [poly(A)+] RNAs were selected by oligo(deoxythymidine)-cellulose column chromatography.

cDNA cloning of mKlk21
The first strand of cDNA was synthesized from poly(A)+ RNA of mouse B16 melanoma cells using a SuperScript preamplification system (Life Technologies, Inc., Tokyo, Japan), according to the manufacturer’s protocol. Two degenerated oligonucleotide PCR primers were synthesized based on the cDNA sequence for conserved regions in mouse Klks (sense primer S1, 5'-TGT GAGAAGAATTCCCAACCC-3', which corresponds to the amino acid sequence NH2-Cys-Glu-Lys-Asn-Ser-Gln-Pro-COOH; antisense primer AS1, 5'-ACCATCACAGATCAGTGGGCC-3', which corresponds to the amino acid sequence NH2-Gly-Pro-Leu-Ile-Cys-Asp-Gly-COOH). cDNAs were amplified under the following conditions: 3 min at 94 C for denaturation; 40 cycles of 1 min at 94 C, 1 min at 58 C for annealing, and 1 min at 72 C for extension; followed by 9-min final extension at 72 C. Fragments between 0.5–0.6 kb in size were recovered from the PCR products by agarose gel electrophoresis. The fragments were subcloned into pBluescript (II) KS+ (Stratagene, La Jolla, CA) cut with EcoRV. Thirty-two clones were obtained from the PCR products after transformation of the recombinant plasmids into Escherichia coli JM109 cells. Among these, one clone (579 bp) was found to be a fragment of mKlk24 cDNA. This cDNA fragment was used as a probe for further experiments.

A mouse testis cDNA library was constructed in {lambda}gt10 with 5 µg poly(A)+ RNA and was packaged using Gigapack III packaging extract (Stratagene). Approximately 4.5 x 105 plaques from the library were transferred to nylon membranes (Schleicher & Schuell, Inc., Dassel, Germany) and hybridized at 65 C in a buffer containing 5x 0.15 M NaCl/8.65 mM NaH2PO4/1.25 mM EDTA (SSPE), 0.5% SDS, 5x Denhardt’s solution (Wako, Osaka, Japan), and 100 µg/ml denatured salmon sperm DNA with the 32P-labeled 579-bp PCR fragment described above. Filters were washed with increasing stringency, with a final wash of 0.1x SSC/0.1% SDS at 50 C. Phage DNA was subcloned into pBluescript (II) KS+ for sequencing. The nucleotide sequence was determined using the ABI automatic sequencer model 377 (PE Applied Biosystems, Foster City, CA).

Northern blot analysis
For preparation of the blot loading total RNA from various mouse tissues, 30 µg total RNA were electrophoresed on a formaldehyde/1.2% agarose gel and transferred to a Nytran Plus membrane (Schleicher & Schuell, Inc.). For preparation of the blot loading total RNAs from mouse testes of various postnatal developmental stages, 25 µg total RNA were electrophoresed on a formaldehyde/1.2% agarose gel and transferred to a Nytran Plus membrane. The blots were hybridized with a 32P-labeled mKlk21-specific oligonucleotide (5'-CATTGCTGTAGTCATCCTCAGGATGTGGGG-3' complementary to nucleotides 404–433), mouse IGF-IA cDNA fragments (GenBank accession no. X04480, nucleotides 81–547), and mouse IGFBP-3 cDNA fragments (GenBank accession no. X81581, nucleotides 478–893). For hybridization with the oligonucleotide probe, blots were hybridized for 18 h at 37 C in a buffer containing 5x SSC, 50 mM sodium acetate (pH 8.0), 0.1% SDS, 10x Denhardt’s solution, 0.01% sodium pyrophosphate, and 100 µg/ml denatured salmon sperm DNA. For hybridization with the cDNA probes, blots were hybridized for 18 h at 42 C in 50% formamide, 5x SSPE, 1% SDS, 5x Denhardt’s solution, and 100 µg/ml denatured salmon sperm DNA. The membranes were washed with increasing stringency, with a final wash of 0.1x SSC/0.1% SDS at 37 C (oligonucleotide probe) or 42 C (cDNA probe).

RT-PCR/Southern blotting
Testis, submaxillary gland, and Leydig cell cDNAs that had been reverse transcribed according to the manufacturer’s protocol from 5 µg of each of the total RNAs using the SuperScript preamplification system (Life Technologies, Inc.) were subjected to PCR using mKlk21-specific primers (mKlk21S, 5'-CGCTACAACAAATATATA-3', corresponding to nucleotides 205–222; mKlk21AS, 5'-CAGCAGATAATGTGACAT-3', complimentary to nucleotides 862–879). The conditions for PCR were 94 C for 3 min, followed by 34 cycles (for comparable PCR) or 25 cycles (for Leydig cells treated with steroid hormones) at 94 C for 1 min, 49 C for 1 min, and 72 C for 1 min. To compare the respective extents of expression of mKlk21 mRNA 5-µl aliquots were removed from the PCR mixtures after every 4 cycles starting at cycle 18. Amplified products were electrophoresed on a 1.5% agarose gel and transferred to a Nytran Plus membrane (Schleicher & Schuell, Inc.). The blots were hybridized with the 32P-labeled mKlk21-specific oligonucleotide probe and processed as described above. Samples were also tested for the expression of ß-actin to confirm the integrity and quantity of RNA.

Preparation of recombinant mKlk21 in E. coli cells
The expression vectors for mKlk21 were constructed by inserting its cDNA (amino acids 18–261), including the complete pro-enzyme region of the mKlk21 gene, into the SalI and XhoI sites of pET30a (Novagen, Madison, WI). PCR using Pfu polymerase (Novagen) was performed with oligonucleotide primers to create SalI sites at the 5'-ends and XhoI sites at the 3'-ends. The reaction product was sequentially digested with SalI and XhoI, gel-purified, and ligated in-frame between the SalI and XhoI sites of expression vector pET30a. After the orientation and sequence of the cDNA in the pET plasmid were confirmed by DNA sequencing, the ligated vector was transformed to E. coli strain BL21 (DE3) pLysS (Novagen). The cells were grown at 37 C, induced with isopropyl-1-thio-ß-D-galactoside. Cells were harvested by centrifuge and were treated in a freeze-thaw process. The materials were washed twice with 0.5% Triton X-100 and solubilized by being dissolved and then incubated in 25 ml 50 mM Tris-HCl (pH 7.6) containing 6 M urea and 0.5 M NaCl for 12 h at room temperature. The solubilized sample was fractionated on a Ni2+-chelate column (5 ml; Novagen) under previously described conditions (13). The eluted protein was dialyzed twice against 2 liters 20 mM Tris-HCl (pH 7.6). The recombinant protein was synthesized as a fusion protein containing 51 extra amino acids, all of which originated from the plasmid sequence, at the NH2-terminus. This fusion protein, which was enzymatically inactive, was then treated at 37 C for 60 min with trypsin immobilized on Sepharose 4B in 20 mM Tris-HCl (pH 7.6) to produce an active mKlk21 by cleaving at the activation site (Arg24-Ile25 in Fig. 1Go). The immobilized protease was removed by filtration, and the resulting filtrate was directly applied to a column of soybean trypsin inhibitor (SBTI)-Sepharose 4B (1 ml bed volume) previously equilibrated with 50 mM Tris-HCl (pH 7.6) containing 0.2 M NaCl. The retained materials were eluted with 0.1 M glycine-HCl buffer (pH 3.0). Fractions of 1 ml were collected in tubes to which 0.2 ml each of 0.1 M Tris-HCl buffer (pH 9) had been added. The enzyme activity of mKlk21 was assayed by a 4-methylcoumaryl-7-amide (MCA)-containing synthetic substrate, Pro-Phe-Arg-MCA. The procedure described above worked satisfactorily for the preparation of active recombinant mKlk21.



View larger version (44K):
[in this window]
[in a new window]
 
Figure 1. Nucleotide and deduced amino acid sequences of mKlk21 cDNA. The putative signal peptide is given in bold. The putative cleavage site for enzyme activation is indicated by an arrowhead. The boxed amino acid residues are catalytic triads conserved in serine proteases. The putative N-glycosylation site is circled. The mKlk21 cDNA sequence has been submitted to the GenBank under accession number AB039276.

 
Enzyme activity assay using various substrates
Enzyme activity toward various MCA substrates (Peptide Institute, Osaka, Japan) was determined in the absence or presence of protease inhibitors according to the method of Barrett (16), with slight modification, as previously described (17).

Zymographic analysis using casein and gelatin was performed according to previously described methods (18).

The assay for the degradation of fibronectin, laminin, type I collagen, and type IV collagen by mKlk21 was performed as previously described (18).

The actions of mKlk21 and mKlk27 on IGFBP-3 were determined by Western blot analysis. A 25-ng sample of human IGFBP-3 (Genzyme, Cambridge, MA) was incubated with 10–100 ng of either recombinant mKlk21 or mKlk27 in 20 µl 100 mM Tris-HCl (pH 8.0) at 37 C. The reaction was stop by heating the sample in the presence of SDS sample buffer. The reaction mixtures were separated on 12% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA). The blotted membrane was incubated with rabbit antihuman IGFBP-3 antibody (American Research Products, Inc., Belmont, MA) at a 1:1000 dilution and subsequently with goat antirabbit IgG antibody (Amersham Pharmacia Biotech, Tokyo, Japan). Immunoreactive signals were detected using an ECL Western blot detection kit (Amersham Pharmacia Biotech) according to the protocol provided by the manufacturer.

Kinin-releasing activity was determined by measurement of the amount of kinin liberated from human low mol wt kininogen (Athens Research and Technology, Inc., Athens, GA) using a Markit bradykinin detection kit (Dainippon Seiyaku, Osaka, Japan).

In situ hybridization analysis of mKlk21 and IGFBP-3 mRNA
Antisense and sense RNA probes of mKlk21 were prepared by in vitro transcription of reverse transcriptase fragments of mKlk21 cDNA (nucleotides 251–722) with T3 or T7 RNA polymerase using a digoxigenin (DIG) RNA labeling kit (Roche, Mannheim, Germany). Antisense and sense RNA probes of mouse IGFBP-3 were prepared by in vitro transcription of reverse transcriptase fragments of IGFBP-3 cDNA (nucleotides 478–893 of GenBank clone X81581) obtained using RT-PCR from testis total RNA. Eight-week-old mouse testis sections (10 µm) were cut on a cryostat, thaw-mounted onto slides coated with silan, and subjected to in situ hybridization as previously described (18) for mKlk21. For IGFBP-3, the sections were treated with 100 ng/ml proteinase K (Roche), postfixed, and acetylated. Prehybridization was performed with hybridization buffer (50% formamide, 6x SSPE, 5x Denhardt’s, and 500 ng/ml tRNA) for 3 h at room temperature. Hybridization was carried out in hybridization buffer containing 200 ng/ml cRNA probes at 60 C for 18 h. The sections were washed three times for 20 min each time in 0.2x SSC at 60 C. The hybridization probes were detected using a DIG nucleic acid detection kit (Roche).

Immunohistochemical detection of IGFBP-3 in a mouse testis section
Frozen testis sections, 10 µm thick, were prepared by using a cryostat, fixed with 100% methanol at -20 C for 10 min, and treated with 3% H2O2 in PBS. After being blocked with BlockAce (Dainippon Seiyaku) for 1 h at room temperature, each section was incubated with antimouse IGFBP-3 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) diluted 1:100 in PBS for 12 h at 4 C. Bound antibodies were detected using an avidin-biotin-peroxidase kit (Vector Laboratories, Inc., Burlingame, CA) according to the manufacturer’s instructions. Immunocomplexes were detected using diaminobenzidine.

Preparation of mouse Leydig cells
For the preparation of mature Leydig cells, the testes from 8-wk-old mice were decapsulated and digested by 0.25 mg/ml collagenase (Life Technologies, Inc.) After sedimentation, Leydig cells contained in the supernatant were purified on a Percoll gradient (19), yielding a preparation containing more than 90% Leydig cells, as judged by {Delta}5-3ß-hydroxysteroid dehydrogenase staining.

In the experiments designed to investigate the hormonal regulation of mKlk21 expression in vitro, immature Leydig cells were isolated without Percoll gradient purification from 2-wk-old mice. Decapsulated testes were incubated for 15 min at 37 C in DMEM/Ham’s F-12 (Life Technologies, Inc.) containing 0.25 mg/ml collagenase. The cells were plated into six-well culture dishes. After 1 h, the Leydig cells had attached to the surface of the plate, whereas the contaminating cells (Sertoli and germ cells) remained unattached. At this time, the medium was discarded, and the wells were washed three times to remove contaminating cells. Fresh medium was added, and the cells were cultured at 37 C in humidified incubator in 95% O2 and 5% CO2.

Hormonal stimulation experiments
Immature Leydig cells from mouse testes were prepared as described above. Twenty-four hours before the experiments, the primary Leydig cell and TM3 cell cultures were placed in fresh medium. For the stimulation experiments, various hormones dissolved in 100% ethanol were added to the culture medium at a final concentration of 10-7 M. Cells stimulated with 100% ethanol were included as controls. The cells were cultured for 48 h and then were harvested for RT-PCR/Southern blot analyses.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cloning of mKlk21
A 579-bp nucleotide fragment amplified by RT-PCR with the primer S1 and AS1 using mouse B16 melanoma cell poly(A)+ RNA was judged to be a partial mKlk24 cDNA because the sequences of GenBank clones M18599 (registered as mouse glandular kallikrein 24, exon 2) and M18619 (registered as mouse glandular kallikrein 24, exon 3) were found in the 5'- and 3'-flanking regions of the fragment, respectively. Screening of an adult mouse testis cDNA library using this DNA fragment as a probe resulted in the identification of 33 positive clones, 5 of which contained full-length cDNA. Two clones coded for mKlk24, and 1 clone coded for mKlk27. The remaining 2 clones were judged to represent mKlk21 cDNA because the sequences of the GenBank clones M18597 (registered as mouse glandular kallikrein 21, exon 2) and M18617 (registered as mouse glandular kallikrein 21, exon 3) were both contained in the nucleotide sequences of these clones. All of the Klks are considered to be functional in vivo, but their biological roles are not yet known. Very recently, mKlk27 has been demonstrated to be a serine protease with chymotrypsin-like specificity (13). For the present study we focused on the serine protease mKlk21.

The nucleotide and the deduced amino acid sequence of mKlk21 cDNA are shown in Fig. 1Go. The nucleotide sequence of 921 bp contains a 5'-region of 75 bp, a putative single open reading frame of 786 bp, and a 3'-untranslated region of 60 bp containing a polyadenylation signal sequence and a poly(A) tail. The open reading frame encodes a protein of 261 amino acids, which includes a hydrophobic signal peptide of 17 amino acids and an NH2-terminal activation peptide of 7 amino acids. The calculated molecular masses of the proprotein and mature protein are 26.7 and 26.0 kDa, respectively. The amino acid residues comprising the active site catalytic triad (His65, Asp120, and Ser213) are all conserved in mKlk21. The protein contains a potential N-glycosylation site (Asn102).

The amino acid sequence of mKlk21 was homologous to those of known mouse Klks. The identity was over 74%. The greatest homology (89% identity) was observed for mKlk27 (13). It was also highly homologous to the amino acid sequences of mKlk24 (88% identity; AB039277), mKlk11 (83% identity) (20), and epidermal growth factor-binding protein A (80% identity) (21).

Expression of mKlk21 mRNA in various mouse tissues
To selectively detect the mKlk21 transcript, an mKlk21-specific oligonucleotide probe was synthesized as described in Materials and Methods. The specificity of this probe was tested by Southern blot analysis using mKlk21, mKlk24, and mKlk27 cDNA. Although the latter two nucleic acid sequences exhibit the greatest sequence homology to mKlk21, the probe was confirmed to hybridize only with mKlk21 cDNA (Fig. 2AGo). Using this oligonucleotide probe, specific signals were detected with total RNAs isolated from adult mouse kidney and testis (Fig. 2BGo).



View larger version (55K):
[in this window]
[in a new window]
 
Figure 2. Expression of mKlk21 mRNA in various tissues. A, Specificity of the 30-mer mKlk21 oligonucleotide probe was tested using the blot loading cDNA for mKlk21, mKlk24, and mKlk27. The cDNAs (50 ng each) were electrophoresed on a 1.2% agarose gel and transferred to a Nytran Plus membrane. The blot was hybridized with the 32P-labeled mKlk21-specific oligonucleotide probe and processed as described in Materials and Methods. B, The blot loading 30 µg total RNA from various tissues of 8-wk-old mice was hybridized with the 30-mer oligonucleotide specific to the mKlk21 gene. Specific signals for mKlk21 mRNA are indicated by an arrow. 18S RNA was used as a loading control. RNA size markers are shown to the left. Five male and five female mice were used to prepare a membrane. Tissues from male mice, except for the ovary, were used. Experiments were conducted twice using different membranes to confirm the reproducibility of the result. C, RT-PCR/Southern blot analysis was performed to compare the expression of mKlk21 mRNA in testis and submaxillary glands. The numbers associated with each lane indicate the PCR cycle numbers from which aliquots of the reaction mixtures were drawn. Experiments were conducted twice using an 8-wk-old mouse in each experiment. For positive and negative controls, PCR/Southern blot analysis was performed using mKlk21, mKlk24, and mKlk27 cDNA as a template with the mKlk21-specific primers under the conditions of 34 cycles. D, The blot loading 30 µg total RNA from the testis at postnatal developmental stages of 2, 4, 6, and 8 wk was used for Northern blot analysis as described in B. Specific signals for mKlk21 mRNA are indicated by an arrow. 18S RNA was used as a loading control. Five animals at each stage were used to isolate total RNA. Two membranes were prepared, and the results of two experiments are shown.

 
We determined the extent of testicular mKlk21 expression relative to the submaxillary glands, in which mRNAs of virtually all kinds of Klks are reported to be detected (14). RT-PCR analysis coupled with Southern blotting revealed that the submaxillary glands appear to express Klk21 mRNA more abundantly than do the testes (Fig. 2CGo). Taking the signal intensities of the amplified products up to 26 cycles of PCR, mKlk21 mRNA level in mouse testis was shown to be less than 1/10th that in the submaxillary glands.

Expression of mKlk21 mRNA in the testis during postnatal development was also examined (Fig. 2DGo). The mKlk21 transcript was detectable at 4 wk after birth and thereafter became more prominent.

Testicular expression of mKlk21 relative to other Klks
We performed RT-PCR using primers corresponding to the conserved regions of all mouse mKlks. RT-PCR amplified products with a size of about 230 bp were gel-purified and subcloned into pBluescript (II) KS+, and the recombinant plasmids were transformed into E. coli, strain JM109. One hundred clones were randomly picked for the nucleotide sequence analyses. Based on these experiments, seven different mKlks were identified. The types and numbers of identified Klks were as follows: mKlk21, 46; mKlk24, 33; mKlk27, 11; mKlk8, 5; mKlk6, 2; mKlk22, 2; and mKlk5, 1. These results indicate that mKlk21 is a dominant mKlk species in the mouse testis.

Enzymatic properties of mKlk21
Under reducing and nonreducing conditions, SDS-PAGE analysis of the active enzyme sample eluted from the SBTI-Sepharose 4B column gave a single polypeptide band (Fig. 3Go). Apparent molecular masses were estimated to be 30 kDa (reducing) and 24 kDa (nonreducing). In our recent study (13) a similar molecular mass difference was observed by SDS-PAGE analysis of mKlk27 under these two conditions.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 3. Assessment of sample purity. Purified mKlk21 was subjected to SDS-PAGE analysis using a 12% gel under reducing and nonreducing conditions. The polypeptide was visualized by silver staining. Molecular masses (kilodaltons) of standard proteins are indicated at the left.

 
The enzyme activity of the recombinant mKlk21 was assayed using various synthetic peptide substrates containing MCA (Table 1Go). Pro-Phe-Arg-MCA was rapidly hydrolyzed by the enzyme. The enzyme also significantly hydrolyzed Z-Phe-Arg-MCA. Some synthetic tripeptide substrates containing arginine at the P1 position were only slightly cleaved by mKlk21. The enzyme showed no activity in the presence of Bz-Arg-MCA, Lys-containing substrate (Boc-Val-Leu-Lys-MCA), or chymotrypsin substrates (Suc-Ala-Ala-Pro-Phe-MCA and Suc-Leu-Leu-Val-Tyr-MCA). The same result was obtained when a different batch of mKlk21 enzyme preparation was used.


View this table:
[in this window]
[in a new window]
 
Table 1. Enzymatic activity of recombinant mKlk21 in the presence of various MCA substrates

 
The effects of various protease inhibitors on the enzyme activity were examined using Pro-Phe-Arg-MCA as a substrate. Enzyme activities were determined in duplicate, and the mean values were obtained. The enzyme activity of mKlk21 was strongly inhibited by diisopropylfluorophosphate (DFP; 89% inhibition at 0.5 mM), leupeptin (97% inhibition at 0.2 mM), and antipain (96% inhibition at 0.1 mM). The enzyme was significantly inhibited with benzamidine (67% inhibition at 1 mM), phenylmethylsulfonylfluoride (PMSF; 57% inhibition at 0.5 mM), and SBTI (44% inhibition at 0.1 mg/ml). No detectable inhibition was observed with N{alpha}-p-tosyl-L-lysine chloromethyl ketone (0.1 mM), N{alpha}-p-tosyl-L-phenylalanine chloromethyl ketone (0.1 mM), chymostatin (0.01 mM), or pepstatin (0.01 mM). Assays with two different batches of enzyme preparation gave the same results. The results described above indicate that mKlk21 is a serine peptidase with trypsin-like substrate specificity.

Activity of mKlk21 in the presence of protein substrates
The hydrolysis of denatured casein and gelatin with mKlk21 was demonstrated by zymographic analysis (Fig. 4AGo). Fibronectin was also degraded with the enzyme, producing four detectable bands, corresponding to 210, 190, 170, and 75 kDa (Fig. 4BGo).



View larger version (39K):
[in this window]
[in a new window]
 
Figure 4. Proteolytic activity of recombinant mKlk21. A, For casein and gelatin zymography, 0.5 µg purified recombinant mKlk21 was loaded on 10% SDS-PAGE gels containing 0.1% casein or 1 mg/ml gelatin. Molecular masses (kilodaltons) of the standard proteins are indicated to the left. B, Human fibronectin (4 µg) was separately incubated without or with mKlk21 (0.5 µg) for 18 h at 37 C and was subjected to SDS-PAGE under nonreducing conditions. After electrophoresis, the gels were stained with Coomassie brilliant blue R-250. Molecular masses (kilodaltons) of the standard proteins are indicated to the left. Experiments were conducted twice to confirm the reproducibility of the result.

 
The effect of mKlk21 on IGFBP-3 was examined (Fig. 5Go). The human IGFBP-3 preparation used in this experiment was a glycosylated form (95%). Therefore, SDS-PAGE/Western blot analysis apparently gave a single band at a position of 41 kDa for intact IGFBP-3. mKlk21 degraded the intact protein in a time-dependent manner (Fig. 5AGo) as well as in a dose-dependent manner (Fig. 5BGo), with concomitant production of the 31-kDa fragment. IGFBP-3 degradation by mKlk21 was examined as a function of pH (Fig. 5CGo). The band intensities of the intact 41-kDa polypeptide were apparently weak at pH 7–9. On the other hand, the 31-kDa degraded form of IGFBP-3 was visualized at pH values in the range 4–10, with no detectable band at pH 8–9. These results indicate that mKlk21 optimally degrades IGFBP-3 at pH 8–9. Disappearance of the 31-kDa polypeptide at these pHs is perhaps due to its further degradation by the enzyme. IGFBP-3 hydrolysis with mKlk21 was inhibited by serine protease inhibitors, such as leupeptin, DFP, PMSF, and SBTI, but not by chymostatin or aprotinin (Fig. 5DGo). We also compared the action of mKlk21 on IGFBP-3 with that of mKlk27, which has recently been demonstrated to hydrolyze the protein (13). In a preliminary experiment, it was found that IGFBP-3 was degraded by mKlk27 much faster than by mKlk21; specifically, when incubation was conducted at the same substrate/enzyme ratio as in Fig. 5AGo, mKlk27 completely degraded the intact IGFBP-3 in 30 min. Figure 5EGo shows the result of IGFBP-3 degradation by mKlk27 under reaction conditions in which the enzyme was reduced to 1/10th. The size of the product was estimated to be 29 kDa, which was slightly smaller than that produced by mKlk21. The above results strongly suggest that mKlk21 and mKlk27 are both active against the naturally occurring glycosylated form of IGFBP-3.



View larger version (51K):
[in this window]
[in a new window]
 
Figure 5. Enzyme activity of mKlk21 toward human recombinant IGFBP-3. A, Human IGFBP-3 (25 ng) was incubated at 37 C with mKlk21 (100 ng) in 20 µl 100 mM Tris-HCl (pH 8.0) for the periods (hours) indicated on the top and was subjected to SDS-PAGE followed by Western blot analysis using anti-IGFBP-3 antibody. B, IGFBP-3 (25 ng) was incubated at 37 C with the indicated amounts of mKlk21 in 20 µl 100 mM Tris-HCl (pH 8.0) for 2 h and was subjected to SDS-PAGE/Western blot analysis as described in A. C, IGFBP-3 (25 ng) was incubated at 37 C with mKlk21 (100 ng) for 2 h in 20 µl 0.1 M sodium acetate (pH 4.0 and 5.0), 0.1 M 2-[N-morpholino]ethanesulfonic acid (pH 6.0), 0.1 M Tris-HCl (pH 7.0 and 8.0), or 0.1 M glycine-NaOH (pH 9.0 and 10.0) and was subjected to SDS-PAGE/Western blot analysis. The pHs tested are indicated on the top. D, IGFBP-3 (25 ng) was incubated at 37 C with mKlk21 (50 ng) for 2 h in 20 µl 0.1 M Tris-HCl (pH 8.0) in the absence or presence of protease inhibitors and was subjected to SDS-PAGE/Western blot analysis. Leupeptin (0.2 mM), DFP (0.5 mM), chymostatin (0.2 mM), PMSF (0.5 mM), SBTI (0.1 mg/ml), and aprotinin (0.1 mg/ml) were used. E, IGFBP-3 (25 ng) was incubated at 37 C with mKlk27 (10 ng) for 2 h in 20 µl 0.1 M Tris-HCl (pH 8.0) for the periods (hours) indicated on the top. The reactions were subjected to SDS-PAGE/Western blot analysis. In all panels, molecular masses (kilodaltons) of standard proteins are indicated to the left, while those of intact (41 kDa) and degraded (31 or 29 kDa) IGFBP-3 polypeptides are indicated to the right. Experiments were conducted at least twice to confirm the reproducibility of the results.

 
Other proteins tested for mKlk21 activity were collagen I and collagen IV, low mol wt kininogen, laminin, and TGFß. None of these proteins was hydrolyzed by this enzyme.

In situ detection of mKlk21 mRNA in the adult mouse testis
Tissue localization of mKlk21 mRNA in the mouse testis was analyzed by in situ hybridization using a DIG-labeled mKlk21 antisense RNA probe. The expression of mKlk21 RNA was specifically localized in the interstitial tissues and was not detected in the seminiferous tubules (Fig. 6AGo). To identify positive cells, further examinations were conducted by staining the neighboring sections with hematoxylin-eosin. Based on the morphological observation that positive cells had eosinophilic cytoplasm (data not shown), we assumed that cells expressing mKlk21 mRNA were Leydig cells situated between the seminiferous tubules. Use of the sense probe produced no significant signals (Fig. 6BGo).



View larger version (155K):
[in this window]
[in a new window]
 
Figure 6. In situ mKlk21 mRNA detection on a section of mouse testis. Two neighboring sections of adult mouse testis were hybridized with an antisense (A) or a sense (B) cRNA probe. Arrows indicate positive signals associated with Leydig cells. A total of three animals were used. Sections were counterstained with methyl green. Bar, 50 µm.

 
Expression of IGFBP-3 mRNA in the mouse testis
To gain some insight into the possible role of mKlk21 in the biological processes involving the IGF-I/IGFBP-3 system, the expression of IGF-I and IGFBP-3 in the mouse testis was examined. Northern blot analysis of IGF-I was conducted using a blot loading total RNAs isolated from the mouse testis at different postnatal developmental stages. Three species (7, 1.8, and 0.7 kb) of IGF-I transcripts were detected in 2-wk-old mouse testes (Fig. 7AGo). During maturation, the abundance of the 7-kb transcript drastically decreased, whereas the expression of the 1.8- and 0.7-kb species apparently remained unchanged. The relative levels of these IGF-I transcripts in the testis were similar to those observed in the liver of the adult mouse (22). In situ detection of IGF-I mRNA using sections of adult mouse testis showed that positive signals were localized at the seminiferous epithelium and Leydig cells in almost equal intensities (data not shown). Expression of IGF-I mRNA in the seminiferous epithelium was previously reported by Baker et al. (23).



View larger version (61K):
[in this window]
[in a new window]
 
Figure 7. Expression of IGF-I and IGFBP-3 mRNA in the mouse testis and Leydig cells isolated from 2- and 8-wk-old mice. A, Total RNA (30 µg) isolated from 2-, 4-, 6-, and 8-wk-old mouse testes was blotted and hybridized with the 32P-labeled 467-nucleotide IGF-IA cDNA fragment. The lower panels show 18S rRNA expression as a control. A total of 10 animals were used to prepare two membranes. A result of two experiments using these two membranes is shown. RNA size markers are shown to the left. B, Two membranes loading 30 µg total RNA isolated from 2-, 4-, 6-, and 8-wk-old mouse testes were prepared. The membranes were hybridized with the 32P-labeled 416-nucleotide IGFBP-3 cDNA fragment. The lower panels show 18S rRNA expression as a control. RNA size markers are shown to the left. A result of two experiments using the two membranes is shown. C, RT-PCR analysis was performed using total RNA isolated from purified testicular Leydig cells of 2- and 8-wk-old mice. A sense primer (5'-CCTGCTCCAGGAAACATCAGTG-3', corresponding to nucleotides 478–499 of the GenBank clone X81581 for mouse IGFBP-3 cDNA) and an antisense primer (5'-TGCCCATACTTGTCCACACACCAG-3', corresponding to nucleotides 870–893 of the same GenBank IGFBP-3 clone) were used. The conditions for PCR were 94 C for 3 min, followed by up to 34 cycles at 94 C for 1 min, 60 C for 1 min, and 72 C for 1 min. The numbers associated with each lane indicate PCR cycle numbers from which aliquots of the reaction mixtures were drawn. The lower panel depicts the amplification of ß-actin mRNA as a control for RNA quantity and integrity. Experiments were conducted twice to confirm the reproducibility of the result.

 
Northern blot analysis revealed an IGFBP-3 transcript of 2.8 kb only during the early stage of postnatal development (Fig. 7BGo). However, Leydig cells isolated from 8-wk-old mice were likely to express more abundant IGFBP-3 transcripts than immature Leydig cells, as demonstrated by RT-PCR analysis (Fig. 7CGo). To examine the intratesticular localization of IGFBP-3 mRNA, an in situ detection analysis was conducted using slices of adult mouse testis. As shown in Fig. 8AGo, the IGFBP-3 transcript was detected in limited areas of both interstitial tissues and seminiferous tubules. Concerning IGFBP-3 expression associated with the interstitial tissues, part of the Leydig cells appeared to express IGFBP-3 mRNA at detectable levels. No significant signals were detected when the sense probe was used. To determine where IGFBP-3 is localized in the testis, the same IGFBP-3 antibody used in the Western blot analysis was used to stain mouse testis sections collected from adult male mice. Immunostaining for IGFBP-3 was observed in interstitial tissues as well as in seminiferous tubules (Fig. 8BGo).



View larger version (137K):
[in this window]
[in a new window]
 
Figure 8. In situ hybridization detection and immunohistochemical detection of IGFBP-3 mRNA and the protein on a section of mouse testis. A, Two neighboring sections of the adult mouse testis were hybridized with an antisense (upper panel) or a sense cRNA (lower panel) probe of IGFBP-3. Signals observed in interstitial tissues are indicated by arrowheads, and signals within seminiferous tubules are indicated by arrows. The reproducibility of the result was confirmed by three experiments. Sections were counterstained with methyl green. Bar, 50 µm. B, Sections of the adult mouse testis were stained with rabbit antihuman IGFBP-3 antibody (upper panel) or without antibody (lower panel). Signals observed in interstitial tissues are indicated by arrowheads, and signals within seminiferous tubules are indicated by arrows. The reproducibility of the result was confirmed by two experiments. Bar, 50 µm.

 
These results indicate that Leydig cells express IGF-I and IGFBP-3. This further suggests the possibility that mKlk21 and IGFBP-3 could be produced simultaneously and that they interact with each other in areas surrounding the Leydig cells of the adult mouse testis.

Effects of various hormones on mKlk21 gene expression
To determine the factors controlling testicular mKlk21 expression, the effects of various hormones were examined using immature Leydig cells isolated from 2-wk-old mouse testes. As the expression level of mKlk21 mRNA in the cells at this stage was very low, we investigated its expression by the RT-PCR/Southern blot analysis method. When immature Leydig cells were treated with T for 48 h, the intensity of the mKlk21 PCR fragment was remarkably enhanced (Fig. 9Go, upper panel). Treatment of the cells with E2 and progesterone caused no significant change. Inclusion of T4 in the culture strongly reduced the expression of the mKlk21 gene. In contrast to the primary immature Leydig cells, the mouse testicular Leydig cell line TM3 prominently responded to E2 treatment (Fig. 9Go, middle panel). Moreover, T significantly increased the level of mKlk21 gene expression. Images of amplified ß-actin confirmed the integrity and quantity of the RNA (Fig. 9Go, lower panel). These results clearly indicate that mKlk21 expression is under control of the male sex hormone T in Leydig cells isolated from immature mouse testes.



View larger version (45K):
[in this window]
[in a new window]
 
Figure 9. Effects of hormones on the expression of the mKlk21 gene in Leydig cells. Testicular Leydig cells isolated from 2-wk-old mice and TM3 Leydig cells were treated with various hormones at 10-7 M for 48 h. Total RNA from the treated cells was subjected to RT-PCR, followed by Southern blot analysis. The lower panel depicts the expression of ß-actin as a control. Five animals were used for one experiment. Experiments were conducted twice to confirm the reproducibility of the results.

 
Degradation of IGFBP-3 by the conditioned medium of Leydig cell culture
We examined whether the conditioned medium of the primary culture of mouse testicular Leydig cells could degrade IGFBP-3. As shown in Fig. 10Go, incubation of IGFBP-3 with the medium isolated from a 2-wk-old immature mouse testis produced no degraded form of the binding protein. On the other hand, medium from the Leydig cell culture of an 8-wk-old mouse testis produced the 31-kDa IGFBP-3 fragment. The production of this fragment was completely inhibited by the serine protease inhibitor PMSF. Leupeptin also inhibited the IGFBP-3-degrading activity of the medium, but chymostatin had no effect. These results indicate that mature mouse testis Leydig cells secrete a leupeptin-sensitive, chymostatin-insensitive serine protease capable of degrading a glycosylated form of IGFBP-3.



View larger version (93K):
[in this window]
[in a new window]
 
Figure 10. Digestion of exogenous IGFBP-3 by the conditioned medium of mature Leydig cell culture. Concentrated culture media (50 µg) from primary Leydig cells from 2- or 8-wk-old mice were incubated with 50 ng human IGFBP-3 for 4 h at 37 C. The reaction mixtures were subjected to SDS-PAGE, followed by Western blot analysis using antihuman IGFBP-3 antibody. For the culture media of testicular Leydig cells isolated from 8-wk-old mice, the effects of PMSF (1 mM), leupeptin (0.2 mM), and chymostatin (0.2 mM) were examined. The molecular masses of intact (41 kDa) and fragment (31 kDa) IGFBP-3 are shown on the right. The molecular masses (kilodaltons) of standard proteins are indicated to the left. Experiments were conducted twice to confirm the reproducibility of the results.

 
We also examined whether endogenous IGFBP-3 would be present in the culture medium of mouse testis Leydig cells, but we failed to detect the binding protein by the current method used in this study.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Existing evidence indicates that in mice the Klk family is composed of at least 16 functional members (4, 13). However, the chemical and enzymatic nature of some Klks remains unclear; mKlk5, mKlk6, mKlk8, mKlk11, mKlk14, mKlk21, and mKlk24 are believed to be functional, but they have not yet been characterized at the protein level (4). We have recently studied the role of Klks in mammalian testis function. Previous studies from other groups (14) and those from our laboratory (13) have documented that the adult mouse testis expresses at least three kinds of Klk mRNA (mKlk21, mKlk24, and mKlk27). Among them, the mKlk21 product was the most abundant, suggesting that mKlk21 plays an important role in this male reproductive organ. The primary focus of the present study was therefore to clarify the chemical identity as well as the enzymatic properties of mKlk21 in the hope of determining its biological function in the testis.

mKlk21 was shown to be a serine protease with trypsin-like cleavage specificity. Examination of the enzyme activity with a variety of synthetic peptide substrates demonstrated that mKlk21 specifically hydrolyzes internal peptide bonds at the carboxyl side of arginine, but not lysine residues. Trypsin-like specificity of mKlk21 was expected due to the fact that the amino acid residue at the position 6 residues to the NH2-terminus from the active site serine is aspartic acid (Asp207 in Fig. 1Go); Asp is thought to be responsible for directing cleavage after basic amino acids (24). However, the present data clearly indicate that the active site of mKlk21 functions such that only arginine at the P1 position of various substrates would be available for hydrolysis. In support of this idea, the serine protease inhibitor N{alpha}-p-tosyl-L-lysine chloromethyl ketone was not observed to affect mKlk21 activity, whereas leupeptin and antipain were potent inhibitors of the enzyme.

In situ hybridization analysis using a 472-bp antisense probe complementary to nucleotides 251–722 of mKlk21 in the testis detected strong signals in association with the Leydig cells. The results were consistent with an observation by Penschow et al. (14). It should be noted that the mKlk21 472-bp nucleotide probe is highly homologous to the corresponding parts of two other mKlks, namely, mKlk24 and mKlk27. These latter two Klks are also expressed simultaneously in the same cells (13). Therefore, one may suspect that Leydig cell-associated signals detected in the current in situ hybridization analysis exhibit a combined expression of mKlk mRNAs, including the mKlk21 transcript itself. We tentatively think that our in situ hybridization signals probably represent the mRNA localization of mKlk21.

In a systematic study of the expression of 12 mouse Klk genes using various tissues from 22-d-old mice, only mKlk21 mRNA was detected in the testis (14). On the other hand, RT-PCR analysis identified 7 different mKlk transcripts in the adult mouse testis. These data together with the present finding that mKlk21 mRNA is expressed most abundantly in the adult testis indicate that mKlk21 remains after puberty in the testis as a dominant type of mKlk.

Our present observation strongly suggests that mKlk21 is synthesized in and secreted from these cells into the extracellular environment, and that the physiological substrate(s) of mKlk21 might be present in the testicular interstitial tissue surrounding Leydig cells. Fibronectin, the extracellular adhesion protein that contributes to organizing the extracellular matrix and helps cells attach to it, is degraded by mKlk21 in vitro. Thus, mKlk21 may be involved in the in vivo turnover of fibronectin. A recent immunohistochemical study by Loveland et al. (25) demonstrated the presence of fibronectin in the seminiferous tubule basement membrane and interstitial matrix of the rat testis throughout development. In the adult testis this adhesion protein was found abundantly and uniformly in the interstitial spaces where Leydig cells are localized. These observations suggest that mKlk21 secreted from Leydig cells readily comes into contact with fibronectin. We tentatively assume that by controlling fibronectin turnover, mKlk21 may play a role in the extracellular matrix remodeling of testicular interstitial tissues.

IGF-I is a polypeptide mitogen that mediates the effects of GH. There is increasing evidence that IGF-I is involved in the autocrine and paracrine regulation of testicular function; IGF-I enhances the differentiated functions of Leydig cells (26). More recently, Baker et al. (23) reported that male mice lacking the IGF-I gene show drastically reduced levels of serum T and infertility. The authors of that study concluded that this hormonal deficiency is due to a significant delay in the differentiation of mutant mouse testis Leydig cells. The activity of IGF-I is known to be modified by binding proteins (27). It has also been reported that both IGF-I and its binding protein (IGFBP-2, -3, and -4) mRNAs are expressed in the Leydig cells of the rat testis and furthermore that IGFBP-3 is a potent inhibitor of IGF-I-induced T formation (28). The present study demonstrates that the mouse testis, like the rat testis, expresses IGF-I and IGFBP-3 genes at detectable levels throughout postnatal development. With respect to the latter gene, the protein was immunohistochemically localized at the interstitial tissues of the testis. These findings indicate that mKlk21, the gene expression of which starts a few weeks after birth, could interact with IGFBP-3 or IGFBP-3 complexed with IGF-I in the vicinity of Leydig cells of the adult mouse testis. Our observation that mKlk21 degrades IGFBP-3 tempts us to speculate that mKlk21 is involved in the maintenance of adult mouse testis Leydig cell function; that is, the mechanism of its actions would include prevention of IGF-I/IGFBP-3 complex formation. Consistent with this idea is the present finding that the culture medium of Leydig cells isolated from adult mouse testes degraded IGFBP-3. The nature of proteases responsible for the binding protein degradation remains to be determined, but it could be mKlk21 for the following two reasons. 1) The relative molecular mass of the major product generated by the putative enzyme was 31 kDa, exactly the same size observed with the recombinant mKlk21. 2) Inhibitor profiles of IGFBP-3 degradation were essentially the same between recombinant mKlk21 and the culture medium. It will be of future interest to determine whether mKlk21 is able to degrade IGFBP-3 bound to IGF-I. In the present study we failed to detect IGFBP-3 in the culture medium of adult mouse testicular Leydig cells by means of Western blot analysis. We presume that the current method was not sensitive enough to detect the binding protein.

We recently reported that mKlk27 also degrades IGFBP-3 (13). Under the hydrolysis conditions of a fixed substrate/enzyme ratio (0.25), the degradation of IGFBP-3 by mKlk27 took place faster than that catalyzed by mKlk21. Based on the disappearance rates of intact 41-kDa IGFBP-3 polypeptide bands as a function of incubation time, the binding protein was determined to be degraded by mKlk27 approximately 10 times more efficiently than by mKlk21. However, this does not indicate that mKlk21 is less important in the process of IGFBP-3 degradation than mKlk27. It should be stressed that mKlk21 expression is apparently much greater than mKlk27 expression in the mouse testis.

A number of studies have previously documented that conditioned media of several cell types, including human fibroblasts (29, 30, 31), bone cells (32), breast cancer cells (33), and rat neuroblastoma cells (34), and biological fluids such as human seminal plasma (35) and ovine ovarian follicular fluids (36) contain proteases capable of degrading IGFBPs. With respect to IGFBP-3 proteolysis, cathepsin D was involved in the case of human fibroblasts, osteoblastic cells, and breast cancer cells (31); PSA in human seminal plasma (35, 37); and mKlk27 in mouse testis Leydig cells (13). Interestingly, PSA and mKlk27 are both chymotrypsin-like serine proteases belonging to a Klk subfamily. In contrast, mKlk21 is a trypsin-like serine protease. As nerve growth factor-{gamma}, the mouse Klk member (mKlk3) characterized as a trypsin-like serine protease, has recently been shown to cleave IGFBP-3 (38), mKlk21 is a second example of IGFBP-3 proteases having trypsin-like specificity. Considering that no significant expression of mKlk3 in the mouse testis has been detected, the contribution of mKlk21 may be solely important in this organ. However, as revealed by testicular gene expression analysis during postnatal development, IGFBP-3 expression is greatest when expression of mKlk21 is very low, and expression of mKlk21 is greatest when that of IGFBP-3 is at its lowest. This fact could argue against the physiological significance of interactions between mKlk21 and IGFBP-3. Further investigations are definitely required to establish the relevance of interactions between these two molecules to the physiological function of the testis.

Previous studies of hormonal regulation of Klk gene expression and/or enzyme activity in salivary glands point to the importance of androgen and thyroid hormones (4, 5, 14). In this study we also observed that mKlk21 mRNA levels in Leydig cells isolated from immature mouse testes were significantly enhanced by T. However, T4 treatment of the cells drastically reduced the expression of this gene, suggesting that this thyroid hormone exerts different effects on gene expression in mouse salivary glands and testicular Leydig cells. It is interesting to note that the commercially available Leydig cell line TM3 exhibited an mKlk21 expression pattern apparently different from that of the primary cultured Leydig cells. Unlike the isolated Leydig cells, ß-E2, but not T, was demonstrated to be the most effective inducer of mKlk21 expression, whereas T4 was without effect in TM3 cells. We observed that mKlk21 mRNA expression patterns in response to hormones vary with the cells used. Such findings indicate that a discussion of gene expression in vivo must proceed with caution. At the present moment, we presume that the mKlk21 expression pattern exhibited by Leydig cells isolated from immature mouse testes in response to various hormones may represent a pattern similar to that of in vivo expression.

In summary, we have characterized the ability of recombinant mKlk21 to degrade fibronectin and IGFBP-3 in vitro. The temporal and spatial expression studies of mKlk21 using mouse testes indicate that mKlk21 may play a role in the testicular Leydig cell function of adult mice. We tentatively suggest that mKlk21 is involved in the degradation of fibronectin and/or IGFBP-3 in the interstitial tissue surrounding the Leydig cells in the mouse testis. Future work directed at elucidating the biological role of this functional mKlk in the testis depends upon current findings with regard to its biochemical and enzymatic properties.


    Acknowledgments
 
We thank Atsushi Kimura (Hokkaido University, Sapporo, Japan) for his valuable suggestions.


    Footnotes
 
This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan. H.M. is supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.

Abbreviations: DFP, Diisopropylfluorophosphate; DIG, digoxigenin; IGFBP-3, IGF-binding protein-3; Klks, kallikreins; MCA, 4-methylcoumaryl-7-amide; mKlk, mouse Klk; PMSF, phenylmethylsulfonylfluoride; poly(A)+, polyadenylated; PSA, prostate-specific antigen; SBTI, soybean trypsin inhibitor; SSPE, 0.15 M NaCl/8.65 mM NaH2PO4/1.25 mM EDTA.

Received January 29, 2001.

Accepted for publication July 25, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Jegou B, Pineau C, Dupaix A 1998 Paracrine control of testis function. In: Wang C, ed. Male reproductive function. London: Kluwer Academic; 41–64
  2. Saez JM, Avallet O, Lejeune H, Chatelain PG 1991 Cell-cell communication in the testis. Horm Res 36:104–115[Medline]
  3. Mason AJ, Evans BA, Cox DR, Shine J, Richards RI 1983 Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature 303:300–307[CrossRef][Medline]
  4. Clements JA 1997 The molecular biology of the kallikreins and their roles in inflammation. In: Farmer S, ed. The kinin system. San Diego: Academic Press; 71–97
  5. Diamandis EP, Yousef GM, Luo I, Magklara I, Obiezu CV 2000 The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol Metab 11:54–60[CrossRef][Medline]
  6. Yousef GM, Obiezu CV, Luo LY, Black MH, Diamandis EP 1999 Prostate/KLK-L1 is a new member of the human kallikrein gene family, is expressed in the prostate and breast tissues and is hormonally regulated. Cancer Res 59:4252–4256[Abstract/Free Full Text]
  7. Yousef GM, Diamandis EP 2000 The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 65:184–194[CrossRef][Medline]
  8. Yousef GM, Luo LY, Diamandis EP 1999 Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res 19:2843–2852[Medline]
  9. Stephenson S, Verity K, Ashworth LK, Clements JA 1999 Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3–13.4. J Biol Chem 274:23210–23214[Abstract/Free Full Text]
  10. Yousef GM, Chang A, Scorilas A, Diamandis EP 2000 Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4 Biochem Biophys Res Commun 276:125–133[CrossRef][Medline]
  11. Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP 2001 Molecular cloning of the human kallikrein 15 gene (KLK15). J Biol Chem 276:53–61[Abstract/Free Full Text]
  12. Chan CS, Harvey MB, Clements 1999 Temporal and tissue-specific expression of kallikrein (Klk) genes and identification of a novel Klk messenger ribonucleic acid transcript during early development in the mouse. Biol Reprod 61:621–628[Abstract/Free Full Text]
  13. Matsui H, Moriyama A, Takahashi T 2000 Cloning and characterization of mouse Klk27, a novel tissue kallikrein expressed in testicular Leydig cells and exhibiting chymotrypsin-like specificity. Eur J Biochem 267:6858–6865[Medline]
  14. Penschow JD, Drinkwater CC, Haralambidis J, Coghlan JP 1991 Sites of expression and induction of glandular kallikrein gene expression in mice. Mol Cell Endocrinol 81:135–146[CrossRef][Medline]
  15. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
  16. Barrett AJ 1980 Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J 187:909–912[Medline]
  17. Matsui H, Ohnishi J, Takahashi T 1998 Proteolytic activation of tissue-type plasminogen activator by the culture media of mouse cancer cells. Zool Sci 15:499–505[Medline]
  18. Matsui H, Kimura A, Yamashiki N, Moriyama A, Kaya M, Yoshida I, Takagi N, Takahashi T 2000 Molecular and biochemical characterization of a serine proteinase predominantly expressed in the medulla oblongata and cerebellar white matter of mouse brain. J Biol Chem 275:11050–11057[Abstract/Free Full Text]
  19. Bernier M, Chatelain P, Mather JP, Saez JM 1986 Regulation of gonadotropin receptors, gonadotropin responsiveness, and cell multiplication by somatomedin-C and insulin in cultured pig Leydig cells. J Cell Physiol 129:257–263[CrossRef][Medline]
  20. Drinkwater CC, Richards RI 1988 Sequence of mGK-11, a mouse glandular kallikrein gene. Nucleic Acids Res 16:10918[Free Full Text]
  21. Drinkwater CC, Evans BA, Richards RI 1987 Mouse glandular kallikrein genes: identification and characterization of the genes encoding the epidermal growth factor binding proteins. Biochemistry 26:6750–6756[CrossRef][Medline]
  22. Singh JS, Rall LB, Styne DM 1991 Insulin-like growth factor I and II gene expression in BALB/c mouse liver during postnatal development. Biol Neonate 60:7–18[Medline]
  23. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR, Efstratiadis A 1996 Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol 10:903–918[Abstract/Free Full Text]
  24. Craik CS, Roczniak S, Largman C, Rutter WJ 1987 The catalytic role of active site aspartic acid in serine proteases. Science 237:909–913[Abstract/Free Full Text]
  25. Loveland K, Schlatt S, Sasaki T, Chu ML, Timpl R, Dziadek M 1998 Developmental changes in the basement membrane of the normal and hypothyroid postnatal rat testis: segmental localization of fibulin-2 and fibronectin. Biol Reprod 58:1123–1130[Abstract/Free Full Text]
  26. Rouiller-Fabre V, Lecref L, Gautier C, Saez JM, Habert R 1998 Expression and effect of insulin-like growth factor I on rat fetal Leydig cell function and differentiation. Endocrinology 139:2926–2934[Abstract/Free Full Text]
  27. Baxter RC 2000 Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol 278:E967–E976
  28. Lin T, Wang D, Nagpal ML, Shimasaki S, Ling N 1993 Expression and regulation of insulin-like growth factor-binding protein-1, -2, -3, and -4 messenger ribonucleic acids in purified rat Leydig cells and their biological effects. Endocrinology 132:1898–1904[Abstract/Free Full Text]
  29. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates III JR, Conover CA 1999 The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149–3153[Abstract/Free Full Text]
  30. Busby WH Jr, Nam TJ, Moralez A, Smith C, Jennings M, Clemmons DR 2000 The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium. J Biol Chem 275:37638–37644[Abstract/Free Full Text]
  31. Conover CA, De Leon DD 1994 Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 269:7076–7080[Abstract/Free Full Text]
  32. Kanzaki S, Hilliker S, Baylink DJ, Mohan S 1994 Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 134:383–392[Abstract/Free Full Text]
  33. Salahifar H, Baxter RC, Martin JL 1997 Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction. Endocrinology 138:1683–1690[Abstract/Free Full Text]
  34. Matsumoto T, Gargosky SE, Kelley K, Rosenfeld RG 1996 Characterization of an insulin-like growth factor binding protein-5 protease produced by rat articular chondrocytes and a neuroblastoma cell line. Growth Regul 6:185–190[Medline]
  35. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75:1046–1053[Abstract]
  36. Besnard N, Pisselet C, Zapf J, Hornebeck W, Monniaux D, Monget P 1996 Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor-binding protein levels during growth and atresia of ovine ovarian follicles. Endocrinology 137:1599–1607[Abstract]
  37. Okabe E, Kajihara J, Usami Y, Hirano K 1999 The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3. FEBS Lett 447:87–90[CrossRef][Medline]
  38. Rajah R, Bhala A, Nunn SE, Peehl DM, Cohen P 1996 7S Nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 137:2676–2682[Abstract]



This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Strauss, J. Kallio, N. Desai, P. Pakarinen, T. Miettinen, H. Gylling, M. Albrecht, S. Makela, A. Mayerhofer, and M. Poutanen
Increased Exposure to Estrogens Disturbs Maturation, Steroidogenesis, and Cholesterol Homeostasis via Estrogen Receptor {alpha} in Adult Mouse Leydig Cells
Endocrinology, June 1, 2009; 150(6): 2865 - 2872.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. Le Magueresse-Battistoni
Serine proteases and serine protease inhibitors in testicular physiology: the plasminogen activation system
Reproduction, December 1, 2007; 134(6): 721 - 729.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. M. Eacker, J. E. Shima, C. M. Connolly, M. Sharma, R. W. Holdcraft, M. D. Griswold, and R. E. Braun
Transcriptional Profiling of Androgen Receptor (AR) Mutants Suggests Instructive and Permissive Roles of AR Signaling in Germ Cell Development
Mol. Endocrinol., April 1, 2007; 21(4): 895 - 907.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Odet, A. Verot, and B. Le Magueresse-Battistoni
The Mouse Testis Is the Source of Various Serine Proteases and Serine Proteinase Inhibitors (SERPINs): Serine Proteases and SERPINs Identified in Leydig Cells Are under Gonadotropin Regulation
Endocrinology, September 1, 2006; 147(9): 4374 - 4383.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Takano, H. Matusi, and T. Takahashi
Granzyme N, a Novel Granzyme, Is Expressed in Spermatocytes and Spermatids of the Mouse Testis
Biol Reprod, December 1, 2004; 71(6): 1785 - 1795.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. J. Spicer
Proteolytic Degradation of Insulin-Like Growth Factor Binding Proteins by Ovarian Follicles: A Control Mechanism for Selection of Dominant Follicles
Biol Reprod, May 1, 2004; 70(5): 1223 - 1230.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Wang, J. Grunler, and M. S. Lewitt
Gender-Specific Pattern of Insulin-Like Growth Factor-Binding Protein-3 Protease Activity in Mouse Thyroid
Endocrinology, March 1, 2004; 145(3): 1137 - 1143.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsui, H.
Right arrow Articles by Takahashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, H.
Right arrow Articles by Takahashi, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals